Search

everythinglearnresearchcommunity

for

Search:↓

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Entrepreneurial companies are key to advancing dermatology treatments and patient care.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Pre-trained Transformers need extreme retraining to perform well on DarkNet data.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Gene differences may affect baldness treatment response in Korean men.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Finasteride blocks progesterone's effect on absence seizures in rats.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Doxazosin mesylate and saw palmetto cause genetic changes in fruit flies.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

New treatments like low-level laser therapy, platelet-rich plasma therapy, and micro needling show positive results for hair regrowth in people with genetic hair loss.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.